Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2

Details for Australian Patent Application No. 2012244071 (hide)

Owner Universiteit Maastricht

Parent 2009227844

Filing date 18 October 2012

Event Publications

1 November 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012244072-Methods and apparatus for treating disorders of the ear, nose and throat

2012244070-Inventory display lock